Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVMM: Probiotics for Vaginal Health in Pregnant Rwandan Women
NCT02150655Phase 1Completed
- Sponsor
- Western University
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lactobacillus rhamnosus gr-1 in bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) (2 arms), sponsored by Western University. Primary endpoint: Maintenance of healthy vaginal microbiota at 1 month. Started Sep 2012; status: completed.
02
Drugs
lactobacillus rhamnosus gr-1
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02150655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150655.